» Authors » Kadir H Sarun

Kadir H Sarun

Explore the profile of Kadir H Sarun including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 155
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Williams M, Cheng Y, Kirschner M, Sarun K, Schelch K, Winata P, et al.
Oncotarget . 2019 Jul; 10(41):4125-4138. PMID: 31289611
MicroRNA downregulation is frequent in malignant pleural mesothelioma (MPM), but the mechanisms responsible for loss of miR-15/16 and miR-193a are yet to be elucidated and were investigated in this study....
2.
Rath E, Cheng Y, Pinese M, Sarun K, Hudson A, Weir C, et al.
PLoS One . 2018 Aug; 13(8):e0203003. PMID: 30157247
Malignant pleural mesothelioma is an aggressive cancer with poor prognosis. Here we have investigated in vitro efficacy of BAMLET and BLAGLET complexes (anti-cancer complexes consisting of oleic acid and bovine...
3.
Johnson T, Schelch K, Cheng Y, Williams M, Sarun K, Kirschner M, et al.
J Thorac Oncol . 2017 Nov; 13(2):258-272. PMID: 29113949
Introduction: Malignant pleural mesothelioma (MPM) is an aggressive malignancy linked to asbestos exposure. On a genomic level, MPM is characterized by frequent chromosomal deletions of tumor suppressors, including microRNAs. MiR-137...
4.
Kao S, Cheng Y, Williams M, Kirschner M, Madore J, Lum T, et al.
J Thorac Oncol . 2017 Jun; 12(9):1421-1433. PMID: 28629895
Introduction: The upregulation of programmed death ligand 1 (PD-L1) is found in many cancers and contributes to evasion of the host's immune defense. In malignant pleural mesothelioma (MPM), PD-L1 expression...
5.
Cheng Y, Wright C, Kirschner M, Williams M, Sarun K, Sytnyk V, et al.
Mol Cancer . 2016 Jun; 15(1):44. PMID: 27245839
Background: Malignant pleural mesothelioma (MPM) is an aggressive, locally invasive, cancer elicited by asbestos exposure and almost invariably a fatal diagnosis. To date, we are one of the leading laboratory...